tiprankstipranks
Prostatype Genomics AB (SE:PROGEN)
:PROGEN
Sweden Market
PROGEN
Prostatype Genomics AB
RESEARCH TOOLSreports
Want to see SE:PROGEN full AI Analyst Report?

Prostatype Genomics AB (PROGEN) Ratios

0 Followers

Prostatype Genomics AB Ratios

SE:PROGEN's free cash flow for Q2 2026 was kr-11.71. For the 2026 fiscal year, SE:PROGEN's free cash flow was decreased by kr and operating cash flow was kr-27.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.04 0.44 1.39 1.06 3.27
Quick Ratio
 0.04 0.43 1.38 1.05 3.26
Cash Ratio
 0.01 0.37 1.11 0.11 1.11
Solvency Ratio
 -1.07 -1.74 -4.60 -1.61 -5.66
Operating Cash Flow Ratio
 -0.63 -0.98 -5.26 -1.19 -6.39
Short-Term Operating Cash Flow Coverage
 0.00 -4.49 -667.30 -2.51 -69.23
Net Current Asset Value
kr -32.03Mkr -13.69Mkr 3.32Mkr 1.36Mkr 9.37M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.10 <0.01 0.24 0.03
Debt-to-Equity Ratio
 0.00 0.20 <0.01 0.47 0.03
Debt-to-Capital Ratio
 0.00 0.17 <0.01 0.32 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 0.02
Financial Leverage Ratio
 6.10 1.92 1.25 1.99 1.18
Debt Service Coverage Ratio
 0.00 -5.34 -21.44 -2.89 -33.61
Interest Coverage Ratio
 0.00 -24.20 -24.36 -25.49 -72.26
Debt to Market Cap
 0.00 0.52 <0.01 0.04 <0.01
Interest Debt Per Share
 0.00 0.20 0.58 3.84 0.55
Net Debt to EBITDA
 0.01 0.10 0.25 -0.24 0.15
Profitability Margins
Gross Profit Margin
-2744.67%-6332.66%963.82%274.93%100.00%
EBIT Margin
-3694.18%-6579.12%-19785.93%-2942.11%-4200.59%
EBITDA Margin
-3478.50%-6210.94%-18791.96%-2803.83%-3921.82%
Operating Profit Margin
-3694.18%-6579.12%-20529.15%-2894.32%-4200.44%
Pretax Profit Margin
-3737.97%-7492.09%-20628.64%-3055.68%-4258.71%
Net Profit Margin
-3737.97%-7492.09%-20628.64%-3055.68%-4258.71%
Continuous Operations Profit Margin
-3737.97%-7492.09%-20628.64%-3055.68%-4258.71%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
101.19%113.88%100.48%105.57%101.39%
Return on Assets (ROA)
-94.97%-87.50%-97.81%-84.18%-93.98%
Return on Equity (ROE)
-229.18%-167.75%-122.65%-167.93%-111.23%
Return on Capital Employed (ROCE)
-572.07%-147.31%-122.06%-158.64%-107.78%
Return on Invested Capital (ROIC)
-572.07%-122.78%-121.82%-108.00%-106.19%
Return on Tangible Assets
-1693.61%-384.41%-323.16%-159.11%-204.26%
Earnings Yield
-479.03%-439.10%-123.13%-13.44%-1.79%
Efficiency Ratios
Receivables Turnover
 0.00 0.40 0.11 0.89 0.27
Payables Turnover
 0.00 13.97 -0.68 -0.25 6.18
Inventory Turnover
 310.16 489.87 -18.09 -11.68 306.57
Fixed Asset Turnover
 2.43 1.31 0.64 22.60 170.75
Asset Turnover
 0.03 0.01 <0.01 0.03 0.02
Working Capital Turnover Ratio
 -0.03 -0.11 0.08 0.24 0.05
Cash Conversion Cycle
 1.18 893.26 3.79K 1.83K 1.28K
Days of Sales Outstanding
 0.00 918.64 3.27K 412.11 1.33K
Days of Inventory Outstanding
 1.18 0.75 -20.17 -31.24 1.19
Days of Payables Outstanding
 0.00 26.13 -535.72 -1.45K 59.10
Operating Cycle
 1.18 919.39 3.25K 380.87 1.34K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.41 -0.70 -14.89 -8.47 -11.99
Free Cash Flow Per Share
 -0.41 -0.71 -17.50 -10.95 -11.99
CapEx Per Share
 <0.01 <0.01 2.62 2.49 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.18 1.29 1.00
Dividend Paid and CapEx Coverage Ratio
 -342.57 -92.25 -5.69 -3.40 0.00
Capital Expenditure Coverage Ratio
 -342.57 -92.25 -5.69 -3.40 0.00
Operating Cash Flow Coverage Ratio
 0.00 -4.49 -667.30 -2.50 -31.94
Operating Cash Flow to Sales Ratio
 -20.61 -40.07 -224.67 -21.49 -40.55
Free Cash Flow Yield
-407.11%-237.38%-157.69%-12.23%-1.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.39 -0.23 -0.81 -7.44 -55.97
Price-to-Sales (P/S) Ratio
 5.08 17.06 167.53 227.40 2.38K
Price-to-Book (P/B) Ratio
 1.21 0.38 1.00 12.50 62.25
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.25 -0.42 -0.63 -8.18 -58.79
Price-to-Operating Cash Flow Ratio
 -0.38 -0.43 -0.75 -10.58 -58.79
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 -0.06 1.70 -3.05
Price-to-Fair Value
 1.21 0.38 1.00 12.50 62.25
Enterprise Value Multiple
 -0.13 -0.17 -0.64 -8.35 -60.63
Enterprise Value
 4.76M 6.37M 23.99M 317.33M 1.62B
EV to EBITDA
 -0.13 -0.17 -0.64 -8.35 -60.63
EV to Sales
 4.69 10.72 120.53 234.02 2.38K
EV to Free Cash Flow
 -0.23 -0.26 -0.46 -8.42 -58.64
EV to Operating Cash Flow
 -0.23 -0.27 -0.54 -10.89 -58.64
Tangible Book Value Per Share
 -0.61 -0.38 1.40 0.43 4.09
Shareholders’ Equity Per Share
 0.13 0.79 11.14 7.17 11.32
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.02 0.02 0.07 0.39 0.30
Net Income Per Share
 -0.75 -1.32 -13.67 -12.04 -12.59
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.01 1.14 1.04 1.04 1.01
Research & Development to Revenue
 2.15 2.46 11.11 2.38 5.14
SG&A to Revenue
 10.68 0.00 78.94 0.00 19.75
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.55 0.53 1.09 0.70 0.95
Currency in SEK